Home » Stocks » Fulgent Genetics

Fulgent Genetics, Inc. (FLGT)

Stock Price: $41.63 USD 0.72 (1.76%)
Updated Aug 12, 2020 4:00 PM EDT - Market closed
After-hours: $43.85 +2.22 (5.33%) Aug 12, 7:37 PM

Stock Price Chart

Key Info

Market Cap 909.07M
Revenue (ttm) 43.75M
Net Income (ttm) 2.53M
Shares Out 21.84M
EPS (ttm) 0.12
PE Ratio 346.92
Forward PE 270.27
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 12, 2020
Last Price $41.63
Previous Close $40.91
Change ($) 0.72
Change (%) 1.76%
Day's Open 41.00
Day's Range 40.50 - 44.79
Day's Volume 593,545
52-Week Range 6.70 - 44.79

More Stats

Market Cap 909.07M
Enterprise Value 890.97M
Earnings Date (est) Nov 9, 2020
Ex-Dividend Date n/a
Shares Outstanding 21.84M
Float 10.64M
EPS (basic) 0.13
EPS (diluted) 0.12
FCF / Share -0.05
Dividend n/a
Dividend Yield n/a
Earnings Yield 0.29%
FCF Yield n/a
Payout Ratio n/a
Shares Short 931,205
Short Ratio 1.90
Short % of Float 8.04%
Beta 1.94
PE Ratio 346.92
Forward PE 270.27
P/FCF Ratio n/a
PS Ratio 20.78
PB Ratio 9.19
Revenue 43.75M
Operating Income 1.83M
Net Income 2.53M
Free Cash Flow -1.15M
Net Cash 18.10M
Net Cash / Share 0.83
Gross Margin 42.10%
Operating Margin 4.17%
Profit Margin 5.80%
FCF Margin -2.63%
ROA 1.50%
ROE 3.66%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 2
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$38.67*
(-7.11% downside)
Low
13.0
Current: $41.63
High
68.0
Target: 38.67
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014
Revenue32.5321.3518.7318.289.581.28
Revenue Growth52.35%13.99%2.48%90.85%649.3%-
Gross Profit18.4210.6510.1811.554.510.34
Operating Income-0.43-5.07-3.480.92-5.01-0.99
Net Income-0.41-5.61-2.51-5.35-8.31-4.28
Shares Outstanding18.7117.9817.7413.7111.84-
Earnings Per Share-0.02-0.31-0.14-1.00-0.61-
Operating Cash Flow5.52-0.681.334.41-0.97-4.40
Capital Expenditures-1.32-2.83-5.36-3.78-2.03-0.73
Free Cash Flow4.20-3.51-4.030.63-3.00-5.13
Cash & Equivalents28.2731.0326.4820.870.490.17
Total Debt2.68-----
Net Cash / Debt25.5931.0326.4820.870.490.17
Assets88.7653.9057.1858.045.832.12
Liabilities5.982.753.013.560.690.44
Book Value82.7851.1554.1854.485.151.68
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Fulgent Genetics, Inc.
Country United States
Employees 139
CEO Ming Hsieh

Stock Information

Ticker Symbol FLGT
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: FLGT
IPO Date September 29, 2016

Description

Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.